
Bioorganic Chemistry (2021)
Update date:2022-08-05
Topics:
Faraji, Aram
Motahari, Rasoul
Hasanvand, Zaman
Oghabi Bakhshaiesh, Tayebeh
Toolabi, Mahsa
Moghimi, Setareh
Firoozpour, Loghman
Boshagh, Mohammad Amin
Rahmani, Roya
Ketabforoosh, Shima H.M.E.
Bijanzadeh, Hamid Reza
Esmaeili, Rezvan
Foroumadi, Alireza
A series of quinazolin-4(3H)-one based agents containing thiadiazole-urea were designed, synthesized, and biologically evaluated. The proliferation rate of PC3 cells was moderately reduced by compound 9f (IC50 = 17.7 μM)which was comparable with sorafenib (IC50 = 17.3 μM). There was also a significant reduction in the number of HUVEC cells, when they were exposed to compound 9y (IC50 = 6.1 μM). To test the potential of compounds in inducing apoptosis, Annexin V-FITC/propidium iodide double staining assay was used. After the treatment of HUVEC cells with 9f, they underwent apoptotic effects. A substantial effort was dedicated to gathering comprehensive data across CAM assay. These data showed that 9f moderately inhibits the growth of corresponding blood vessels. Finally, the outcomes of Western blotting proposed a mechanism of action, by which the phosphorylation of VEGFR-2 is inhibited by compounds 9f and 9y.
View MoreContact:+86-21-6856-1349 523-87676172
Address:No16 . BinJiang Road . Taixing Economy Developing Area .JiangSu Province . China
Springchem New Material Technology Co.,Limited
website:http://www.spring-chem.com
Contact:86-21-62885108
Address:602B, Building 1, No. 641, Tianshan Road
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Suzhou Sibian Chemical Technology Co., Ltd
website:http://www.sibianpharm.com
Contact:+8618169181984,+8618013186906
Address:Room1404,BuildingA,Jiabao Square No.323 Baodai East Road,Wuzhong District,Suzhou Jiangsu China (215128)
Shenzhen HwaGen Pharmaceutical Co., Ltd
website:http://www.rafflespt.com
Contact:+86-752-5538396
Address:Guangdong Huizhou China
Doi:10.1021/jm0256068
(2003)Doi:10.1016/S0040-4039(00)00909-6
(2000)Doi:10.1021/ja01871a501
(1939)Doi:10.1039/CT9242500854
(1924)Doi:10.1039/c6cc08891k
(2017)Doi:10.1246/bcsj.55.1137
(1982)